BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Bio Marketing

Aptamer Group and BizCom announce collaboration for Optimer distribution and marketing services in Japan

This agreement gives BizCom non-exclusive rights to market and sell Optimer discovery and development services in Japan. The Optimer platform consis...

September 29, 2021 | News

South Korea Advances Treatment of Polymyositis

Immunoforge (Co-CEOs Sung-min Ahn, Kiho Chang), a company specializing in developing new drugs for rare musculoskeletal diseases, has reported that th...

September 28, 2021 | News

ACROMEC's associated Life Science Incubator launches Co-working Labspace

ACROMEC Limited a specialist engineering services provider, announced that subsidiary ACROMEC Engineers Pte Ltd (ACROMEC Engineers) through joint-venture a...

September 24, 2021 | News

Happiness Biotech Announced The Launch of Its Lucidum Tablets

"To prevent false advertisement in the healthcare industry and prohibit defective health products from entering the market, China has set forth s...

September 13, 2021 | News

Enzene Biosciences Ltd. obtains a Marketing Authorization for its Denosumab Biosimilar drug in India

Osteoporosis is a commonly occurring condition associated with advanced age, and is frequently caused by oestrogen decline in post-menopausal women. It can...

August 29, 2021 | News

Kintor Pharma Collaborates with Etana to Commercialize Proxalutamide to treat Covid19

Pursuant to the Licensing Agreement, Kintor Pharma will receive from Etana upfront and milestone payments, in addition to the economic benefit relating to ...

August 26, 2021 | News

Penpulimab Monoclonal Antibody (PD-1) Obtains Marketing Approval in China

This approval of Penpulimab by the NMPA is based on a multicenter, single-arm, open-label pivotal clinical trial. Patients enrolled were r/r cHL ...

August 06, 2021 | News

Yuyu Pharma Signs Exclusive Distribution Agreement with Novartis Korea

Yuyu Pharma, a pharmaceutical company based in Korea, and Novartis Korea announced today that the companies have entered into an agreement in which Yuyu wi...

August 04, 2021 | News

Canon Medical Announces Strategic Changes to Reinforce Global HIT Division

The HIT division will broaden its capabilities and leverage Canon Medical’s global infrastructure to accelerate the delivery of a full range of Enter...

July 23, 2021 | News

Enzymatica and STADA extend agreement on ViruProtect to Vietnam

Enzymatica has licensed to STADA exclusive rights to market and sell ViruProtect® (distributed by Enzymatica as ColdZyme®) in Vietnam. ...

July 14, 2021 | News

Beazley expands healthcare and life sciences capability in Asia

Specialist insurer Beazley has appointed Prashansa Daga as Miscellaneous Medical & Life Sciences underwriter to support the expansion of its Healthcare...

July 12, 2021 | News

Bora Group announce the rebranding of Yuta Health to Bora Health

With the name change, Bora plans to complete the merging of the operations of Bora Health and Union Chemical & Pharmaceutical by the end of 2021. In th...

July 06, 2021 | News

Peijia Medical leads China into the "Retrievable Era" using TAVR products

The TaurusElite® Transcatheter Aortic Valve Replacement System (hereinafter referred to as "TaurusElite®") developed by Peijia Medical (9996.H...

June 28, 2021 | News

Behaviour change campaigns in pharma

Top 5 takeaways1. Behaviour change campaigns can help modify long-standing habits2. Challenge for pharma is understanding how to influe...

June 17, 2021 | Opinion | By Jo Spink

Stay Connected